Aytu Biopharma (AYTU) Cash & Equivalents Growth (3y) (2017 - 2026)
Aytu Biopharma (AYTU) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 21.81% |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 11.05% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -4.92% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 7.80% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 19.10% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 12.11% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 27.55% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 13.03% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 32.82% |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | 11.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.68% |
| Dec 31, 2025 | 15.47% |
| Sep 30, 2025 | 11.07% |
| Jun 30, 2025 | 16.93% |
| Mar 31, 2025 | -13.02% |
| Dec 31, 2024 | -16.69% |
| Sep 30, 2024 | -20.69% |
| Jun 30, 2024 | -26.26% |
| Dec 31, 2023 | -31.97% |
| Sep 30, 2023 | -19.25% |
| Jun 30, 2023 | -21.81% |
| Mar 31, 2023 | -32.47% |
| Dec 31, 2022 | 54.78% |
| Sep 30, 2022 | 50.29% |
| Jun 30, 2022 | 20.57% |
| Mar 31, 2022 | 23.53% |
| Dec 31, 2021 | 25.60% |
| Sep 30, 2021 | 116.63% |
| Jun 30, 2021 | 92.34% |
| Dec 31, 2020 | 151.31% |